Filter News
Area of Research
News Topics
- (-) Biomedical (12)
- 3-D Printing/Advanced Manufacturing (24)
- Advanced Reactors (8)
- Artificial Intelligence (5)
- Big Data (1)
- Bioenergy (12)
- Biology (8)
- Biotechnology (1)
- Buildings (6)
- Chemical Sciences (25)
- Clean Water (1)
- Climate Change (5)
- Composites (7)
- Computer Science (18)
- Coronavirus (8)
- Critical Materials (13)
- Cybersecurity (6)
- Decarbonization (7)
- Energy Storage (29)
- Environment (11)
- Exascale Computing (1)
- Frontier (3)
- Fusion (7)
- Grid (3)
- High-Performance Computing (3)
- Isotopes (9)
- ITER (1)
- Machine Learning (2)
- Materials (54)
- Materials Science (60)
- Microscopy (18)
- Molten Salt (6)
- Nanotechnology (31)
- National Security (3)
- Net Zero (1)
- Neutron Science (66)
- Nuclear Energy (23)
- Partnerships (8)
- Physics (19)
- Polymers (12)
- Quantum Computing (2)
- Quantum Science (17)
- Renewable Energy (1)
- Security (2)
- Space Exploration (7)
- Summit (4)
- Sustainable Energy (14)
- Transformational Challenge Reactor (2)
- Transportation (13)
Media Contacts
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.